Pfizer Disappointed by Study Results - WSJ.com

Links shared publicly online about this topic.

  • 1,350
    total visits

Pfizer Disappointed by Study Results - WSJ.com

online.wsj.com

Pfizer ended a Phase III trial for its experimental lung-cancer drug and said two studies of its advanced breast-cancer drug failed to meet their primary endpoints.

View full resource at online.wsj.com

Tags:

  • Share

Most Recently Shared on March 13, 2010 at 12:53 am By:

DrEliaz Dr Issac Eliaz

WSJ.com - Pfizer Disappointed in Study Results for Two Drugs http://on.wsj.com/aMMI9y

3 years ago...

Positive Top-Line Results For Pfizer's Lyrica In Phase 3 Study Of Patients With Fibromyalgia In Japan

medicalnewstoday.com — “Pfizer Japan announced today the top-line results for Lyrica (pregabalin) Study A0081208 - Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate Efficacy and Safety of PregabView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 6, 2011 at 5:06 pm By:

mnt_fibromyal MNT Fibromyalgia Health News

Positive Top-Line Results For Pfizer's Lyrica In Phase 3 Study Of Patients With Fibromyalgia In Japan http://mnt.to/3Y3t #fibromyalgia

2 years ago...

Advertisement